{"id":"NCT04066023","sponsor":"Zosano Pharma Corporation","briefTitle":"Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches","officialTitle":"Randomized, Double-Blind, Multi-Center, Parallel-Group Comparison of the Efficacy and Safety of the C213 (Zolmitriptan Microneedle System) to Placebo for the Acute Treatment of Cluster Headaches","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2019-10-03","primaryCompletion":"2021-04-14","completion":"2021-04-14","firstPosted":"2019-08-22","resultsPosted":"2022-05-02","lastUpdate":"2022-06-14"},"enrollment":42,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cluster Headache"],"interventions":[{"type":"DRUG","name":"C213 Microneedle System","otherNames":["Zolmitriptan Microneedle System"]},{"type":"DRUG","name":"Placebo","otherNames":["ZP Placebo"]}],"arms":[{"label":"C213 1.9 mg","type":"EXPERIMENTAL"},{"label":"C213 3.8mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a double-blind, placebo-controlled study. Subjects who meet the entry criteria will be randomized o receive one of three blinded treatments \\[C213 1.9 mg patch and placebo patch; C213 3.8 mg (1.9 mg x 2 patches), two placebo patches\\] on Day 1 and will have up to 48 weeks to confirm and treat a cluster headache. Subjects will self-administer the patches and respond to questions in the electronic diary (eDiary) until 1-hour post treatment administration.","primaryOutcome":{"measure":"Percentage of Subjects Who Achieve Pain Relief","timeFrame":"15 minutes","effectByArm":[{"arm":"Placebo","deltaMin":3,"sd":null},{"arm":"C213 1.9 mg","deltaMin":5,"sd":null},{"arm":"C213 3.8mg","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":["Application site erythema","Corona virus infection","Sunburn","Application site oedema","Application site bruise"]}}